Passer au contenu Aller au pied de page
Pegfilgrastim-Fpgk: Benefits, Reviews, Info, Side Effects!
Détails de la prescription
Pegfilgrastim-Fpgk
Neulasta, Fulphila, Udenyca
Pegfilgrastim
Biologic
Médicaments
Biological Product
stimulates white blood cell production, reduces risk of infection during chemotherapy, supports immune system, decreases incidence of febrile neutropenia, aids in recovery of bone marrow function
Back Pain, Bone Pain, Dizziness, Fatigue, Fever, Headache, Injection Site Reactions, Nausea, Pain In Arms Or Legs, Rash
Pegfilgrastim-Fpgk is a biosimilar to pegfilgrastim, which is used to reduce the risk of infection in patients undergoing chemotherapy by stimulating the production of white blood cells. The typical dosage for pegfilgrastim, including its biosimilars, is usually a single subcutaneous injection of 6 mg per chemotherapy cycle. However, the exact dosage and administration schedule can vary based on the specific treatment regimen and patient needs. It’s important to follow the prescribing healthcare provider’s instructions and the specific product labeling for the correct dosage.
Neutropenia, chemotherapy-induced neutropenia
Generally well-tolerated with common side effects like bone pain and headache.
Aucune interaction signalée
$3,900

Un résumé de

Pegfilgrastim-Fpgk

Pegfilgrastim-Fpgk is a medication that is commonly used in the treatment of patients undergoing chemotherapy. It belongs to a class of drugs known as colony-stimulating factors, which work by stimulating the production of white blood cells in the body. This is important because chemotherapy can often suppress the immune system, leaving patients vulnerable to infections.

One of the key benefits of Pegfilgrastim-Fpgk is its ability to reduce the risk of infection in patients undergoing chemotherapy. By boosting the production of white blood cells, it helps to strengthen the immune system and protect against potentially harmful infections. This can be particularly important for patients with certain types of cancer who may already have weakened immune systems.

Pegfilgrastim-Fpgk is typically administered as an injection under the skin, usually within 24 hours after chemotherapy. It is important to follow your healthcare provider’s instructions carefully when using this medication to ensure that you receive the full benefits.

As with any medication, Pegfilgrastim-Fpgk may cause side effects in some patients. Common side effects may include bone pain, muscle aches, and fatigue. It is important to discuss any concerns or side effects with your healthcare provider.

Overall, Pegfilgrastim-Fpgk is an important medication for patients undergoing chemotherapy to help reduce the risk of infection and support a healthy immune system. If you have any questions or concerns about this medication, be sure to speak with your healthcare provider for more information.

Avis de non-responsabilité juridique de RxDb

Les informations fournies sur RxDB.net sont fournies à titre informatif uniquement et ne sont pas destinées à remplacer un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours un professionnel de la santé qualifié, tel qu'un médecin ou un pharmacien, pour toute question ou préoccupation concernant votre santé, vos médicaments ou votre état de santé. Vous vous fiez entièrement aux informations fournies sur ce site Web à vos propres risques. RxDB.net ne fournit pas de services médicaux ou pharmaceutiques et n'est pas responsable des décisions prises sur la base des informations contenues dans le présent document.

DERNIÈRE MISE À JOUR DE LA PAGE

0
J'aimerais connaître votre avis, n'hésitez pas à commenter.x
fr_CAFR